how are glp-1 drugs made Glucagon-like peptide-1 receptor: mechanisms and advances in therapy The GLP-1 boom: Challenges, trends,
Description
QImaging, Surrey, Canada) coupled to the microscope
MonamiMVitaleVAmbrosioMLBartoliNToffanelloGRagghiantiBet al
Figure S14
These adverse events lead some patients to discontinue therapy before achieving optimal clinical outcomes, reducing long-term treatment adherence
